3 – Stability of monoclonal antibodies (mAbs)

Chemical and physical degradation pathways for degradation of monoclonal antibodies are reviewed. Emphasis has been placed on understanding the basic chemical and physical degradation route mechanisms to enable a rationale approach for formulation development.

[1]  G. Monard,et al.  Computational study on nonenzymatic peptide bond cleavage at asparagine and aspartic acid. , 2008, The journal of physical chemistry. A.

[2]  D. Brems,et al.  Inverse Relationship of Protein Concentration and Aggregation , 2002, Pharmaceutical Research.

[3]  Steven J. Shire,et al.  Mechanisms of aggregate formation and carbohydrate excipient stabilization of lyophilized humanized monoclonal antibody formulations , 2003, AAPS PharmSci.

[4]  J. Bergès,et al.  Oxidation of protein tyrosine or methionine residues: From the amino acid to the peptide , 2011 .

[5]  Marisa K Joubert,et al.  Classification and Characterization of Therapeutic Antibody Aggregates , 2011, The Journal of Biological Chemistry.

[6]  H. Wright.  Sequence and structure determinants of the nonenzymatic deamidation of asparagine and glutamine residues in proteins. , 1991, Protein engineering.

[7]  V. Katta,et al.  Identification of isomerization and racemization of aspartate in the Asp-Asp motifs of a therapeutic protein. , 2011, Analytical biochemistry.

[8]  R. Lerner,et al.  Antibody Catalysis of the Oxidation of Water , 2001, Science.

[9]  Alavattam Sreedhara,et al.  Role of surface exposed tryptophan as substrate generators for the antibody catalyzed water oxidation pathway. , 2013, Molecular pharmaceutics.

[10]  Ming Li,et al.  Human IgG2 Antibodies Display Disulfide-mediated Structural Isoforms* , 2008, Journal of Biological Chemistry.

[11]  R. Ionescu,et al.  Heterogeneity of monoclonal antibodies revealed by charge-sensitive methods. , 2008, Current pharmaceutical biotechnology.

[12]  T. Ueda,et al.  Isolation and characterization of 101-succinimide lysozyme that possesses the cyclic imide at Asp101-Gly102. , 1994, Biochemistry.

[13]  W. Adam,et al.  Oxidation of indoles by singlet oxygen and dimethyldioxirane: Isolation of indole dioxetanes and epoxides by stabilization through nitrogen acylation , 1993 .

[14]  Shahid Uddin,et al.  Determining Antibody Stability: Creation of Solid‐Liquid Interfacial Effects within a High Shear Environment , 2007, Biotechnology progress.

[15]  B. Chakrabarti,et al.  STUDIES ON HUMAN LENS: I. ORIGIN AND DEVELOPMENT OF FLUORESCENT PIGMENTS , 1984, Photochemistry and photobiology.

[16]  Chung C. Hsu,et al.  Replacing succinate with glycolate buffer improves the stability of lyophilized interferon-γ , 1996 .

[17]  Wei Zhang,et al.  Free Sulfhydryl in Recombinant Monoclonal Antibodies , 2002, Biotechnology progress.

[18]  P. Privalov,et al.  A thermodynamic approach to the problem of stabilization of globular protein structure: a calorimetric study. , 1974, Journal of molecular biology.

[19]  S. Shire.  Stability characterization and formulation development of recombinant human deoxyribonuclease I [Pulmozyme, (dornase alpha)]. , 1996, Pharmaceutical biotechnology.

[20]  V. Sharma,et al.  Oxidation of Amino Acids, Peptides and Proteins by Ozone: A Review , 2010 .

[21]  K. Dill,et al.  The protein folding problem. , 1993, Annual review of biophysics.

[22]  R. Amadó,et al.  Formation of dityrosine cross-links in proteins by oxidation of tyrosine residues. , 1976, Biochimica et biophysica acta.

[23]  Fred Jacobson,et al.  Protein aggregation and bioprocessing , 2006, The AAPS Journal.

[24]  G H Snyder,et al.  Electrostatic influence of local cysteine environments on disulfide exchange kinetics. , 1981, Biochemistry.

[25]  J. M. Beals,et al.  In vivo deamidation characterization of monoclonal antibody by LC/MS/MS. , 2005, Analytical chemistry.

[26]  E. Stadtman,et al.  Reactive oxygen-mediated protein oxidation in aging and disease. , 1998, Drug metabolism reviews.

[27]  Theodore W Randolph,et al.  IgG particle formation during filling pump operation: a case study of heterogeneous nucleation on stainless steel nanoparticles. , 2009, Journal of pharmaceutical sciences.

[28]  G M Whitesides,et al.  Rates of thiol-disulfide interchange reactions involving proteins and kinetic measurements of thiol pKa values. , 1980, Biochemistry.

[29]  A. B. Robinson,et al.  Sequence dependent deamidation rates for model peptides of cytochrome C. , 2009, International journal of peptide and protein research.

[30]  M. Gilson,et al.  The determinants of pKas in proteins. , 1996, Biochemistry.

[31]  Y John Wang,et al.  Methionine, tryptophan, and histidine oxidation in a model protein, PTH: mechanisms and stabilization. , 2009, Journal of pharmaceutical sciences.

[32]  J. B. Bogardus,et al.  Chemical and Physical Stability of Chimeric L6, a Mouse−Human Monoclonal Antibody , 1994, Pharmaceutical Research.

[33]  M. Oda,et al.  Review Antibody flexibility observed in antigen binding and its subsequent signaling , 2004 .

[34]  Daniel J. Kroon,et al.  Identification of Sites of Degradation in a Therapeutic Monoclonal Antibody by Peptide Mapping , 1992, Pharmaceutical Research.

[35]  A. Pirie.  Formation of N'-formylkynurenine in proteins from lens and other sources by exposure to sunlight. , 1971, The Biochemical journal.

[36]  J. Ring,et al.  Anaphylactoid reactions to infusions of plasma protein and human serum albumin Role of aggregated proteins and of stabilizers added during production , 1979, Clinical allergy.

[37]  R Tyler-Cross,et al.  Effects of amino acid sequence, buffers, and ionic strength on the rate and mechanism of deamidation of asparagine residues in small peptides. , 1991, The Journal of biological chemistry.

[38]  Yang Wang,et al.  Impact of methionine oxidation in human IgG1 Fc on serum half-life of monoclonal antibodies. , 2011, Molecular immunology.

[39]  R. Borchardt,et al.  Stability of Protein Pharmaceuticals , 1989, Pharmaceutical Research.

[40]  E. Barron,et al.  The oxidation of dithiols. , 1947, The Biochemical journal.

[41]  Rita L. Wong,et al.  Asparagine deamidation dependence on buffer type, pH, and temperature. , 2013, Journal of pharmaceutical sciences.

[42]  J. Schultz.  [28] Cleavage at aspartic acid , 1967 .

[43]  M. E. Ryan,et al.  Averse Effects of Intravenous Immunoglobulin Therapy , 1996, Clinical pediatrics.

[44]  S. Burman,et al.  Facile method of quantification for oxidized tryptophan degradants of monoclonal antibody by mixed mode ultra performance liquid chromatography. , 2012, Journal of chromatography. A.

[45]  R. Borchardt,et al.  Evidence for the involvement of histidine A(12) in the aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation. , 2000, Biochemistry.

[46]  R T Borchardt,et al.  Chemical instability of protein pharmaceuticals: Mechanisms of oxidation and strategies for stabilization. , 1995, Biotechnology and bioengineering.

[47]  W. Burkitt,et al.  Conformational changes in oxidatively stressed monoclonal antibodies studied by hydrogen exchange mass spectrometry , 2010, Protein science : a publication of the Protein Society.

[48]  E. Stadtman,et al.  Oxidation of free amino acids and amino acid residues in proteins by radiolysis and by metal-catalyzed reactions. , 1993, Annual review of biochemistry.

[49]  S. Pontremoli,et al.  Evidence of a critical histidine residue in 6-phosphogluconate dehydrogenase from Candida utilis. , 1968, Biochemistry.

[50]  Hongcheng Liu,et al.  Analysis of reduced monoclonal antibodies using size exclusion chromatography coupled with mass spectrometry , 2009, Journal of the American Society for Mass Spectrometry.

[51]  Hanns-Christian Mahler,et al.  Shaken, not stirred: mechanical stress testing of an IgG1 antibody. , 2008, Journal of pharmaceutical sciences.

[52]  C. Anfinsen.  Principles that govern the folding of protein chains. , 1973, Science.

[53]  Hui Zhao,et al.  Characterization of the photodegradation of a human IgG1 monoclonal antibody formulated as a high-concentration liquid dosage form. , 2009, Journal of pharmaceutical sciences.

[54]  J. Andrade,et al.  Proteins at Interfaces: Principles, Multivariate Aspects, Protein Resistant Surfaces, and Direct Imaging and Manipulation of Adsorbed Proteins , 1992 .

[55]  Hanns-Christian Mahler,et al.  Induction and analysis of aggregates in a liquid IgG1-antibody formulation. , 2005, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[56]  Andreas Petzold,et al.  Identification of Potential Sites for Tryptophan Oxidation in Recombinant Antibodies Using tert-Butylhydroperoxide and Quantitative LC-MS , 2011, PloS one.

[57]  Wei Wang,et al.  Antibody structure, instability, and formulation. , 2007, Journal of pharmaceutical sciences.

[58]  L. Mazzarella,et al.  Kinetics and mechanism of succinimide ring formation in the deamidation process of asparagine residues , 1993 .

[59]  K. Dill,et al.  The Protein Folding Problem , 1993 .

[60]  T. Nguyen,et al.  The Kinetics of Relaxin Oxidation by Hydrogen Peroxide , 1993, Pharmaceutical Research.

[61]  D. Urry,et al.  Nonenzymatic deamidation of asparaginyl and glutaminyl residues in proteins. , 1991, Critical reviews in biochemistry and molecular biology.

[62]  R. Houghten,et al.  Human somatotropin. Reaction with hydrogen peroxide. , 1977, Archives of biochemistry and biophysics.

[63]  Bernard R Brooks,et al.  A comprehensive picture of non-site specific oxidation of methionine residues by peroxides in protein pharmaceuticals. , 2004, Journal of pharmaceutical sciences.

[64]  Steven J. Shire,et al.  The Effect of Formulation Excipients on Protein Stability and Aerosol Performance of Spray-Dried Powders of a Recombinant Humanized Anti-IgE Monoclonal Antibody1 , 1999, Pharmaceutical Research.

[65]  R. Jefferis,et al.  Interaction sites on human IgG-Fc for FcγR: current models , 2002 .

[66]  S. Clarke,et al.  Deamidation, isomerization, and racemization at asparaginyl and aspartyl residues in peptides. Succinimide-linked reactions that contribute to protein degradation. , 1987, The Journal of biological chemistry.

[67]  J. Carpenter,et al.  Use of infrared spectroscopy to assess secondary structure of human growth hormone within biodegradable microspheres. , 1999, Journal of pharmaceutical sciences.

[68]  J L Cleland,et al.  The development of stable protein formulations: a close look at protein aggregation, deamidation, and oxidation. , 1993, Critical reviews in therapeutic drug carrier systems.

[69]  B. Barry,et al.  Reactive oxygen and oxidative stress: N-formyl kynurenine in photosystem II and non-photosynthetic proteins , 2012, Photosynthesis Research.

[70]  J. Dillon,et al.  Photooxidation of specific residues in alpha-crystallin polypeptides. , 1991, Biochemistry.

[71]  J. Casas-Finet,et al.  A systematic multitechnique approach for detection and characterization of reversible self-association during formulation development of therapeutic antibodies. , 2013, Journal of pharmaceutical sciences.

[72]  I. Sizer,et al.  The oxidation of tyramine, tyrosine, and related compounds by peroxidase. , 1959, The Journal of biological chemistry.

[73]  J. Stults,et al.  Isolation and characterization of a succinimide variant of methionyl human growth hormone. , 1991, The Journal of biological chemistry.

[74]  E. C. Beuvery,et al.  Analytical Approaches to the Study of Monoclonal Antibody Stability , 1990, Pharmaceutical Research.

[75]  S. Clarke.  Propensity for spontaneous succinimide formation from aspartyl and asparaginyl residues in cellular proteins. , 2009, International journal of peptide and protein research.

[76]  Randall J Mrsny,et al.  Formulation and delivery issues for monoclonal antibody therapeutics. , 2006, Advanced drug delivery reviews.

[77]  R. Ratner,et al.  Persistent Cutaneous Insulin Allergy Resulting From High-Molecular-Weight Insulin Aggregates , 1990, Diabetes.

[78]  M. Parker,et al.  Peculiar spectroscopic and kinetic properties of Cys-47 in human placental glutathione transferase. Evidence for an atypical thiolate ion pair near the active site. , 1993, The Journal of biological chemistry.

[79]  Anthony G. Fane,et al.  Fouling mechanisms of membranes during protein ultrafiltration , 1992 .

[80]  S. Clarke,et al.  Spontaneous degradation of polypeptides at aspartyl and asparaginyl residues: Effects of the solvent dielectric , 1993, Protein science : a publication of the Protein Society.

[81]  Rao Pe,et al.  Orthoclone OKT3. Chemical mechanisms and functional effects of degradation of a therapeutic monoclonal antibody. , 1993 .

[82]  Jack Y. Zheng,et al.  Influence of pH, buffer species, and storage temperature on physicochemical stability of a humanized monoclonal antibody LA298. , 2006, International journal of pharmaceutics.

[83]  Thomas M. Dillon,et al.  Structural and Functional Characterization of Disulfide Isoforms of the Human IgG2 Subclass* , 2008, Journal of Biological Chemistry.

[84]  I. B. C. Matheson,et al.  CHEMICAL REACTION RATES OF AMINO ACIDS WITH SINGLET OXYGEN , 1979 .

[85]  S. Müller,et al.  Modulation of antigenicity related to changes in antibody flexibility upon lyophilization. , 2001, Journal of molecular biology.

[86]  J. Trent,et al.  Understanding base-assisted desulfurization using a variety of disulfide-bridged peptides. , 2003, Biopolymers.

[87]  Min Huang,et al.  Frozen State Storage Instability of a Monoclonal Antibody: Aggregation as a Consequence of Trehalose Crystallization and Protein Unfolding , 2011, Pharmaceutical Research.

[88]  K. Dill,et al.  The Protein-Folding Problem, 50 Years On , 2012, Science.

[89]  C Russell Middaugh,et al.  Spectroscopic evaluation of the stabilization of humanized monoclonal antibodies in amino acid formulations. , 2007, International journal of pharmaceutics.

[90]  Ziping Wei,et al.  Characterization of a novel modification to monoclonal antibodies: thioether cross-link of heavy and light chains. , 2005, Analytical chemistry.

[91]  J. Carpenter,et al.  Effects of solution conditions, processing parameters, and container materials on aggregation of a monoclonal antibody during freeze-thawing. , 2008, Journal of pharmaceutical sciences.

[92]  R. Biltonen,et al.  Validity of the “two‐state” hypothesis for conformational transitions of proteins , 1966, Biopolymers.

[93]  Hongcheng Liu,et al.  Effect of methionine oxidation of a recombinant monoclonal antibody on the binding affinity to protein A and protein G. , 2008, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[94]  C Russell Middaugh,et al.  Excipients differentially influence the conformational stability and pretransition dynamics of two IgG1 monoclonal antibodies. , 2012, Journal of pharmaceutical sciences.

[95]  E. Canova‐Davis,et al.  Metal-catalyzed photooxidation of histidine in human growth hormone. , 1997, Analytical biochemistry.

[96]  A. Ohtsu,et al.  The effect of pH, hydrogen peroxide and temperature on the stability of human monoclonal antibody. , 1996, Journal of pharmaceutical and biomedical analysis.

[97]  C. Foote,et al.  CHEMISTRY OF SINGLET OXYGEN—XXV. PHOTOOXYGENATION OF METHIONINE * , 1977 .

[98]  Max Tejada,et al.  Identification and characterization of buried unpaired cysteines in a recombinant monoclonal IgG1 antibody. , 2012, Analytical chemistry.

[99]  Douglas S Rehder,et al.  Identification and characterization of deamidation sites in the conserved regions of human immunoglobulin gamma antibodies. , 2005, Analytical chemistry.

[100]  Hongcheng Liu,et al.  Disulfide bond structures of IgG molecules , 2012, mAbs.

[101]  R. Borchardt,et al.  Chemical Pathways of Peptide Degradation. I. Deamidation of Adrenocorticotropic Hormone , 1990, Pharmaceutical Research.

[102]  Steven Kozlowski,et al.  Overlooking subvisible particles in therapeutic protein products: gaps that may compromise product quality. , 2009, Journal of pharmaceutical sciences.

[103]  K. Uchida,et al.  Site-specific oxidation of angiotensin I by copper(II) and L-ascorbate: conversion of histidine residues to 2-imidazolones. , 1990, Archives of biochemistry and biophysics.

[104]  E. E. Dubinina,et al.  Oxidative Modification of Proteins: Oxidation of Tryptophan and Production of Dityrosine in Purified Proteins Using Fenton's System , 2002, Biochemistry (Moscow).

[105]  T. Dillon,et al.  Conformational implications of an inversed pH-dependent antibody aggregation. , 2009, Journal of pharmaceutical sciences.

[106]  T. Florence.  Degradation of protein disulphide bonds in dilute alkali. , 1980, The Biochemical journal.

[107]  E. Gabellieri,et al.  Proteins in frozen solutions: evidence of ice-induced partial unfolding. , 1996, Biophysical journal.

[108]  K. Schey,et al.  Identification of tryptophan oxidation products in bovine α‐crystallin , 1998, Protein science : a publication of the Protein Society.

[109]  R. Jaenicke,et al.  Stability and stabilization of globular proteins in solution. , 2000, Journal of biotechnology.

[110]  M. Davies,et al.  Photo-oxidation of proteins , 2012, Photochemical & Photobiological Sciences.

[111]  M. Tomita,et al.  Sensitized photooxidation of histidine and its derivatives. Products and mechanism of the reaction. , 1969, Biochemistry.

[112]  Thomayant Prueksaritanont,et al.  Impact of methionine oxidation on the binding of human IgG1 to Fc Rn and Fc gamma receptors. , 2009, Molecular immunology.

[113]  R. Levine,et al.  Determination of 2-oxohistidine by amino acid analysis. , 1995, Analytical biochemistry.

[114]  A. Mitra,et al.  Differential Effects of Anionic, Cationic, Nonionic, and Physiologic Surfactants on the Dissociation, α-Chymotryptic Degradation, and Enteral Absorption of Insulin Hexamers , 1993, Pharmaceutical Research.

[115]  V. Schirch,et al.  Role of peptide conformation in the rate and mechanism of deamidation of asparaginyl residues. , 1988, Biochemistry.

[116]  P. Kolhe,et al.  Impact of freezing on pH of buffered solutions and consequences for monoclonal antibody aggregation , 2009, Biotechnology progress.

[117]  Joey Pollastrini,et al.  Response of a concentrated monoclonal antibody formulation to high shear , 2009, Biotechnology and bioengineering.

[118]  Reed J. Harris,et al.  Non-enzymatic hinge region fragmentation of antibodies in solution. , 2005, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[119]  K. Uchida.  Histidine and lysine as targets of oxidative modification , 2003, Amino Acids.

[120]  J. Hong,et al.  Metal-catalyzed Oxidation of Histidine in Human Growth Hormone , 1997, The Journal of Biological Chemistry.

[121]  Hongcheng Liu,et al.  Heterogeneity of monoclonal antibodies. , 2008, Journal of pharmaceutical sciences.

[122]  A. B. Robinson,et al.  Rates of nonenzymatic deamidation of glutaminyl and asparaginyl residues in pentapeptides. , 1973, Journal of the American Chemical Society.

[123]  M. Manning,et al.  Effect of zinc binding and precipitation on structures of recombinant human growth hormone and nerve growth factor. , 2000, Journal of pharmaceutical sciences.

[124]  B. Kabakoff,et al.  Identification of multiple sources of charge heterogeneity in a recombinant antibody. , 2001, Journal of chromatography. B, Biomedical sciences and applications.

[125]  J. King,et al.  The Reactivity and Oxidation Pathway of Cysteine 232 in Recombinant Human α1-Antitrypsin* , 2002, The Journal of Biological Chemistry.

[126]  B. Violand,et al.  Isolation and characterization of porcine somatotropin containing a succinimide residue in place of aspartate129 , 1992, Protein science : a publication of the Protein Society.

[127]  H. Friesen,et al.  Methionine oxidation in human growth hormone and human chorionic somatomammotropin. Effects on receptor binding and biological activities. , 1987, The Journal of biological chemistry.

[128]  Hongcheng Liu,et al.  Method to differentiate asn deamidation that occurred prior to and during sample preparation of a monoclonal antibody. , 2008, Analytical chemistry.

[129]  J. V. Van Wyk,et al.  Restoration of growth by human growth hormone (Roos) in hypopituitary dwarfs immunized by other human growth hormone preparations: clinical and immunological studies. , 1974, The Journal of clinical endocrinology and metabolism.

[130]  S. Capasso,et al.  Effect of the three-dimensional structure on the deamidation reaction of ribonuclease A. , 1999, The journal of peptide research : official journal of the American Peptide Society.

[131]  Linda O. Narhi,et al.  Effect of Ions on Agitation- and Temperature-Induced Aggregation Reactions of Antibodies , 2009, Pharmaceutical Research.

[132]  S. Shire,et al.  Self-association of human and porcine relaxin as assessed by analytical ultracentrifugation and circular dichroism. , 1991, Biochemistry.

[133]  N. Kitabatake,et al.  Heat-induced formation of intermolecular disulfide linkages between thaumatin molecules that do not contain cysteine residues. , 1999, Journal of agricultural and food chemistry.

[134]  R. Borchardt,et al.  Chemical Pathways of Peptide Degradation. III. Effect of Primary Sequence on the Pathways of Deamidation of Asparaginyl Residues in Hexapeptides , 1990, Pharmaceutical Research.

[135]  N. Robinson,et al.  Prediction of protein deamidation rates from primary and three-dimensional structure , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[136]  C. Schöneich,et al.  Mechanisms of metal-catalyzed oxidation of histidine to 2-oxo-histidine in peptides and proteins. , 2000, Journal of pharmaceutical and biomedical analysis.

[137]  A. Vermeer,et al.  Adsorption of IgG onto hydrophobic teflon. Differences between the F(ab) and F(c) domains. , 2001, Biochimica et biophysica acta.

[138]  Theodore W Randolph,et al.  Aggregation of a monoclonal antibody induced by adsorption to stainless steel , 2010, Biotechnology and bioengineering.

[139]  E. Canova‐Davis,et al.  Characterization of chemically synthesized human relaxin by high-performance liquid chromatography. , 1990, Journal of chromatography.

[140]  Chung C. Hsu,et al.  Site-Specific Tryptophan Oxidation Induced by Autocatalytic Reaction of Polysorbate 20 in Protein Formulation , 2011, Pharmaceutical Research.

[141]  J. Brown,et al.  Formulation development of an antifibrin monoclonal antibody radiopharmaceutical. , 1996, Pharmaceutical biotechnology.

[142]  Brian M. Murphy,et al.  Stability of Protein Pharmaceuticals: An Update , 2010, Pharmaceutical Research.

[143]  B. Thomas,et al.  N5-Methylasparagine and asparagine as nucleophiles in peptides : main-chain vs side-chain amide cleavage , 1993 .

[144]  R. L. Baldwin,et al.  The sequential unfolding of ribonuclease A: detection of a fast initial phase in the kinetics of unfolding. , 1971, Proceedings of the National Academy of Sciences of the United States of America.

[145]  H. Smyth,et al.  The influence of formulation and spacer device on the in vitro performance of solution chlorofluorocarbon-free propellant-driven metered dose inhalers , 2004, AAPS PharmSciTech.

[146]  Linda O. Narhi,et al.  Chemical Modifications in Therapeutic Protein Aggregates Generated under Different Stress Conditions , 2011, The Journal of Biological Chemistry.

[147]  J L Cleland,et al.  Antioxidants for prevention of methionine oxidation in recombinant monoclonal antibody HER2. , 1997, Journal of pharmaceutical sciences.

[148]  A. Alexander,et al.  Monitoring of IgG antibody thermal stability by micellar electrokinetic capillary chromatography and matrix-assisted laser desorption/ionization mass spectrometry. , 1995, Analytical chemistry.

[149]  Bhuwan Dhingra,et al.  A compendium and hydropathy/flexibility analysis of common reactive sites in proteins: reactivity at Asn, Asp, Gln, and Met motifs in neutral pH solution. , 1996, Pharmaceutical biotechnology.

[150]  R. Levine.  Oxidative modification of glutamine synthetase. I. Inactivation is due to loss of one histidine residue. , 1983, The Journal of biological chemistry.

[151]  Jolon M. Dyer,et al.  Characterisation of photo-oxidation products within photoyellowed wool proteins: tryptophan and tyrosine derived chromophores , 2006, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

[152]  S. Singh,et al.  An industry perspective on the monitoring of subvisible particles as a quality attribute for protein therapeutics. , 2010, Journal of pharmaceutical sciences.

[153]  W. Jiskoot,et al.  Identification of oxidation sites and covalent cross-links in metal catalyzed oxidized interferon Beta-1a: potential implications for protein aggregation and immunogenicity. , 2013, Molecular pharmaceutics.

[154]  L. Presta,et al.  Isomerization of an aspartic acid residue in the complementarity-determining regions of a recombinant antibody to human IgE: identification and effect on binding affinity. , 1996, Biochemistry.

[155]  R. Gurny,et al.  Where disease pathogenesis meets protein formulation: renal deposition of immunoglobulin aggregates. , 2006, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[156]  Ronald T. Borchardt,et al.  Chemical Pathways of Peptide Degradation. II. Kinetics of Deamidation of an Asparaginyl Residue in a Model Hexapeptide , 1990, Pharmaceutical Research.

[157]  Ronald T Borchardt,et al.  Aspartate isomerization in the complementarity-determining regions of two closely related monoclonal antibodies. , 2007, Biochemistry.

[158]  A. B. Robinson,et al.  Deamidation of glutaminyl residues: dependence on pH, temperature, and ionic strength. , 1974, Analytical biochemistry.

[159]  A. Vermeer,et al.  Structural changes of IgG induced by heat treatment and by adsorption onto a hydrophobic Teflon surface studied by circular dichroism spectroscopy. , 1998, Biochimica et biophysica acta.

[160]  S Banu Ozkan,et al.  The protein folding problem: when will it be solved? , 2007, Current opinion in structural biology.

[161]  T. Maciag,et al.  Inactivation of human fibroblast growth factor-1 (FGF-1) activity by interaction with copper ions involves FGF-1 dimer formation induced by copper-catalyzed oxidation. , 1992, The Journal of biological chemistry.

[162]  D. Chelius,et al.  Identification and characterization of oxidation and deamidation sites in monoclonal rat/mouse hybrid antibodies. , 2010, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[163]  J. Tamada,et al.  Kinetics of insulin aggregation in aqueous solutions upon agitation in the presence of hydrophobic surfaces. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[164]  E. Maggio.  Use of excipients to control aggregation in peptide and protein formulations , 2010 .

[165]  T. H. Nguyen,et al.  Aggregation and precipitation of human relaxin induced by metal-catalyzed oxidation. , 1995, Biochemistry.

[166]  A. Kossiakoff,et al.  Tertiary structure is a principal determinant to protein deamidation. , 1988, Science.

[167]  R. Borchardt,et al.  Chemical Pathways of Peptide Degradation. IV. Pathways, Kinetics, and Mechanism of Degradation of an Aspartyl Residue in a Model Hexapeptide , 2004, Pharmaceutical Research.

[168]  C. Topham,et al.  Ionization characteristics of the Cys-25/His-159 interactive system and of the modulatory group of papain: resolution of ambiguity by electronic perturbation of the quasi-2-mercaptopyridine leaving group in a new pyrimidyl disulphide reactivity probe. , 1993, The Biochemical journal.

[169]  K. Sharp,et al.  On the calculation of pKas in proteins , 1993, Proteins.

[170]  Ziping Wei,et al.  Identification of a single tryptophan residue as critical for binding activity in a humanized monoclonal antibody against respiratory syncytial virus. , 2007, Analytical chemistry.

[171]  W. D. de Jong,et al.  Spontaneous peptide bond cleavage in aging alpha-crystallin through a succinimide intermediate. , 1988, The Journal of biological chemistry.

[172]  N. Robinson,et al.  Molecular clocks. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[173]  W V Moore,et al.  Role of aggregated human growth hormone (hGH) in development of antibodies to hGH. , 1980, The Journal of clinical endocrinology and metabolism.

[174]  H. Scheraga,et al.  Deamidation of the asparaginyl-glycyl sequence. , 2009, International journal of peptide and protein research.

[175]  Hendrik Zipse,et al.  ACCELERATED RACEMIZATION OF ASPARTIC ACID AND ASPARAGINE RESIDUES VIA SUCCINIMIDE INTERMEDIATES : AN AB INITIO THEORETICAL EXPLORATION OF MECHANISM , 1996 .

[176]  R J Harris,et al.  Processing of C-terminal lysine and arginine residues of proteins isolated from mammalian cell culture. , 1995, Journal of chromatography. A.

[177]  Gerald M. Edelman,et al.  THE COVALENT STRUCTURE OF AN ENTIRE γG IMMUNOGLOBULIN MOLECULE , 1969 .

[178]  The protein folding problem: Searching conformations of compact chain molecule , 1995 .

[179]  E. Stadtman,et al.  Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. , 1990, Free radical biology & medicine.

[180]  Characterization of the Isomerization Products of Aspartate Residues at Two Different Sites in a Monoclonal Antibody , 2011, Pharmaceutical Research.

[181]  P. Doran.  Loss of secreted antibody from transgenic plant tissue cultures due to surface adsorption. , 2006, Journal of biotechnology.

[182]  A. B. Robinson,et al.  Deamidation of asparaginyl residues as a hazard in experimental protein and peptide procedures. , 1971, Analytical biochemistry.

[183]  A. Shahzamani,et al.  A month–long effect from a single injection of microencapsulated human growth hormone , 1996, Nature Medicine.

[184]  David Creed,et al.  THE PHOTOPHYSICS AND PHOTOCHEMISTRY OF THE NEAR‐UV ABSORBING AMINO ACIDS–I. TRYPTOPHAN AND ITS SIMPLE DERIVATIVES , 1984 .

[185]  A. S. Inglis.  [28] Cleavage at aspartic acid , 1983 .

[186]  Gideon Schreiber,et al.  Kinetic studies of protein-protein interactions. , 2002, Current opinion in structural biology.

[187]  R. Borchardt,et al.  Chemical Pathways of Peptide Degradation. VIII. Oxidation of Methionine in Small Model Peptides by Prooxidant/Transition Metal Ion Systems: Influence of Selective Scavengers for Reactive Oxygen Intermediates , 1995, Pharmaceutical Research.